Suivre
Markus H Kainulainen
Markus H Kainulainen
Viral Special Pathogens Branch, Centers for Disease Control and Prevention
Adresse e-mail validée de cdc.gov
Titre
Citée par
Citée par
Année
Persistence of Ebola virus in ocular fluid during convalescence
JB Varkey, JG Shantha, I Crozier, CS Kraft, GM Lyon, AK Mehta, G Kumar, ...
New England Journal of Medicine 372 (25), 2423-2427, 2015
4962015
Ebola virus persistence in semen of male survivors
TM Uyeki, BR Erickson, S Brown, AK McElroy, D Cannon, A Gibbons, ...
Clinical Infectious Diseases 62 (12), 1552-1555, 2016
1202016
Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication
A Baer, D Austin, A Narayanan, T Popova, M Kainulainen, C Bailey, ...
Journal of Biological Chemistry 287 (10), 7399-7410, 2012
962012
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH
M Kainulainen, M Habjan, P Hubel, L Busch, S Lau, J Colinge, ...
Journal of virology 88 (6), 3464-3473, 2014
872014
NSs virulence factor of rift valley fever virus engages the F-box proteins FBXW11 and β-TRCP1 to degrade the antiviral protein kinase PKR
M Kainulainen, S Lau, CE Samuel, V Hornung, F Weber
Journal of virology 90 (13), 6140-6147, 2016
652016
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
FEM Scholte, JR Spengler, SR Welch, JR Harmon, JAD Coleman-McCray, ...
Emerging Microbes & Infections 8 (1), 575-578, 2019
412019
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
L Wang, MH Kainulainen, N Jiang, H Di, G Bonenfant, L Mills, M Currier, ...
Nature communications 13 (1), 4350, 2022
382022
Antibody-mediated virus neutralization is not a universal mechanism of Marburg, Ebola, or Sosuga virus clearance in Egyptian rousette bats
AJ Schuh, BR Amman, TK Sealy, MH Kainulainen, AK Chakrabarti, ...
The Journal of infectious diseases 219 (11), 1716-1721, 2019
382019
Ebola virus disease diagnostics, Sierra Leone: Analysis of real-time reverse transcription–polymerase chain reaction values for clinical blood and oral swab specimens
BR Erickson, TK Sealy, T Flietstra, L Morgan, B Kargbo, VE Matt-Lebby, ...
The Journal of Infectious Diseases 214 (suppl_3), S258-S262, 2016
312016
Use of a scalable replicon-particle vaccine to protect against lethal Lassa virus infection in the guinea pig model
MH Kainulainen, JR Spengler, SR Welch, JAD Coleman-McCray, ...
The Journal of infectious diseases 217 (12), 1957-1966, 2018
302018
eIF2B as a target for viral evasion of PKR-mediated translation inhibition
JD Wuerth, M Habjan, M Kainulainen, B Berisha, D Bertheloot, ...
MBio 11 (4), 10.1128/mbio. 00976-20, 2020
18*2020
Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles
MH Kainulainen, JR Spengler, SR Welch, JAD Coleman-McCray, ...
The Journal of infectious diseases 220 (8), 1281-1289, 2019
182019
The S genome segment is sufficient to maintain pathogenicity in intra-clade Lassa virus reassortants in a guinea pig model
SR Welch, FEM Scholte, CG Albariño, MH Kainulainen, ...
Frontiers in Cellular and Infection Microbiology 8, 240, 2018
182018
Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies
AP Chapman, X Tang, JR Lee, A Chida, K Mercer, RE Wharton, ...
Scientific Reports 11 (1), 9682, 2021
172021
Lassa virus targeting of anterior uvea and endothelium of cornea and conjunctiva in eye of guinea pig model
JM Gary, SR Welch, JM Ritter, JA Coleman-McCray, T Huynh, ...
Emerging Infectious Diseases 25 (5), 865, 2019
172019
High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
MH Kainulainen, E Bergeron, P Chatterjee, AP Chapman, J Lee, A Chida, ...
Scientific Reports 11 (1), 12330, 2021
152021
Transmission of SARS‐CoV‐2 Delta variant (B. 1.617. 2) from a fully vaccinated human to a canine in Georgia, July 2021
NM Wendling, A Carpenter, A Liew, RR Ghai, N Gallardo‐Romero, ...
Zoonoses and Public Health 69 (5), 587-592, 2022
132022
Rapid determination of ebolavirus infectivity in clinical samples using a novel reporter cell line
MH Kainulainen, ST Nichol, CG Albariño, CF Spiropoulou
The Journal of infectious diseases 216 (11), 1380-1385, 2017
122017
Virus fitness differences observed between two naturally occurring isolates of Ebola virus Makona variant using a reverse genetics approach
CG Albariño, LW Guerrero, AK Chakrabarti, MH Kainulainen, ...
Virology 496, 237-243, 2016
112016
GPS Tracking of Free-Roaming Cats (Felis catus) on SARS-CoV-2-Infected Mink Farms in Utah
BR Amman, CM Cossaboom, NM Wendling, RR Harvey, H Rettler, ...
Viruses 14 (10), 2131, 2022
102022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20